Lexaria Bioscience - Warrants (11/01/2026) Accounts Payable

As of the most recent data (May 2026), LEXXW shows a accounts payable of $350K. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LEXXW's accounts payable is now $350K (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Lexaria Bioscience - Warrants (11/01/2026) is outperforming or lagging.

Tracking LEXXW's accounts payable over time shows whether Lexaria Bioscience - Warrants (11/01/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $350K In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Lexaria Bioscience - Warrants (11/01/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $350K) with ownership activity and broader fundamentals.

Lexaria Bioscience - Warrants (11/01/2026)'s accounts payable is $350K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.